Trade this ETF at your broker
Fund size | EUR 109 m |
Total expense ratio | 0.18% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Fund currency | EUR |
Currency risk | Currency hedged |
Volatility 1 year (in EUR) | 13.61% |
Inception/ Listing Date | 15 June 2020 |
Distribution policy | Distributing |
Distribution frequency | Quarterly |
Fund domicile | Ireland |
Fund Provider | iShares |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | State Street Fund Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Deloitte |
Fiscal Year End | 30 November |
Swiss representative | BlackRock Asset Management Schweiz AG |
Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
Tax data | Bundesanzeiger | |
Germany | 30% tax rebate | |
Switzerland | Unknown | |
Austria | Unknown | |
UK | UK Reporting |
Indextype | - |
Swap counterparty | - |
Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
Securities lending | Yes |
Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
UNITEDHEALTH GRP. INC | 10.71% |
ELI LILLY & CO | 9.54% |
JOHNSON & JOHNSON | 7.71% |
MERCK & CO INC ORD | 5.63% |
ABBVIE ORD SHS | 5.38% |
PFIZER ORD | 3.72% |
THERMO FISHER SCIENTIFIC INC | 3.71% |
ABBOTT LABORATORIES | 3.54% |
AMGEN INC | 2.95% |
DANAHER CORP | 2.72% |
United States | 96.67% |
Ireland | 2.47% |
Other | 0.86% |
Health Care | 99.15% |
Other | 0.85% |
YTD | -4.33% |
1 month | +2.44% |
3 months | -0.46% |
6 months | +0.65% |
1 year | -6.87% |
3 years | +13.69% |
5 years | - |
Since inception (MAX) | +27.75% |
2022 | -5.83% |
2021 | +24.95% |
2020 | - |
2019 | - |
Current dividend yield | 1.28% |
Dividends (last 12 months) | EUR 0.08 |
Period | Dividend in EUR | Dividend yield in % |
---|---|---|
1 Year | EUR 0.08 | 1.20% |
2022 | EUR 0.08 | 1.12% |
2021 | EUR 0.08 | 1.31% |
Volatility 1 year | 13.61% |
Volatility 3 years | 16.32% |
Volatility 5 years | - |
Return per risk 1 year | -0.50 |
Return per risk 3 years | 0.14 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -13.12% |
Maximum drawdown 3 years | -17.20% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -17.20% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | IUHE | - - | - - | - |
Euronext Amsterdam | EUR | IUHE | IUHE NA | IUHE.AS |
Fund name | Fund Size in m € (AuM) | TER in % p.a. | Distribution policy | Replication method |
---|---|---|---|---|
iShares S&P 500 Health Care Sector UCITS ETF (Acc) | 1,884 | 0.15% p.a. | Accumulating | Full replication |
Xtrackers MSCI USA Health Care UCITS ETF 1D | 937 | 0.12% p.a. | Distributing | Full replication |
Invesco Nasdaq Biotech UCITS ETF | 484 | 0.40% p.a. | Accumulating | Swap-based |
iShares Nasdaq US Biotechnology UCITS ETF | 376 | 0.35% p.a. | Accumulating | Sampling |
SPDR S&P US Health Care Select Sector UCITS ETF | 312 | 0.15% p.a. | Accumulating | Full replication |